Perspective Therapeutics, Inc.
CATX· NYSE
CATXPerspective Therapeutics, Inc.
Filed Mar 28, 2024 · 10-K · 88 days after period end · 0001437749-24-009696
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | — | — | $1.92M | $1.60M |
| Net Income | -$24.68M | -$3.27M | -$1.10M | -$2.34M |
| EPS Diluted | — | — | -$0.02 | -$0.04 |
Perspective Therapeutics, Inc. · CIK 728387 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2023 · filed Mar 28, 2024 · 88 d after period end
